Dongcha Beating AI said that OpenAI will acquire biotech company Orchestra Bio and integrate its team and technology into the life sciences platform Rosalind.
PANews, citing OpenAI an official announcement, said that OpenAI has acquired the drug R&D collaboration platform Orchestra Bio, and plans to integrate its team and technology into the life sciences AI model and tool, Rosalind.
bibibi.cc